These side effects had been notably milder compared to an inhibitor of each bromodomains. An in depth molecular Assessment also disclosed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor - "Our study exposed the essential job on the KLF16/MYC regulatory axis in modulating tumor https://abbv-744-in-acute-myeloid00134.blogsmine.com/32418233/getting-my-abbv-744-brd4-inhibitor-clinical-efficacy-in-refractory-cancers-to-work